Cargando…
Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis
SIMPLE SUMMARY: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has been introduced in order to improve outcomes for selected patients with peritoneal surface malignancies. Although survival benefits have been widely reported in the literature, this treatment is still not accept...
Autores principales: | Carboni, Fabio, Valle, Mario, Vaira, Marco, Sammartino, Paolo, Federici, Orietta, Robella, Manuela, Deraco, Marcello, Framarini, Massimo, Macrì, Antonio, Sassaroli, Cinzia, Lippolis, Piero Vincenzo, Di Giorgio, Andrea, Biacchi, Daniele, Martin-Roman, Lorena, Sperduti, Isabella, Baratti, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741330/ https://www.ncbi.nlm.nih.gov/pubmed/36497306 http://dx.doi.org/10.3390/cancers14235824 |
Ejemplares similares
-
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal Surface Malignancies Oncoteam—S.I.C.O.’
por: Marano, Luigi, et al.
Publicado: (2021) -
Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review
por: Sommariva, Antonio, et al.
Publicado: (2022) -
Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
por: Pasqual, Enrico Maria, et al.
Publicado: (2023) -
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience
por: Carboni, Fabio, et al.
Publicado: (2021) -
Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
por: Marrelli, Daniele, et al.
Publicado: (2022)